Making the complex EU AI Act more accessible for pathology labs is crucial for safe and effective AI adoption in healthcare. That’s why, through a great collaboration – including our CMO Thomas Van Den Berghe, a practical checklist and framework have been developed to help both laboratories and AI vendors implement AI tools confidently in clinical workflows.
Many thanks to all authors for the smooth collaboration: Frederik Deman · Sofia Palmieri · Glenn Broeckx· Thomas Van Den Berghe · Inti Zlobec · Peter Schirmacher · Sara Pires de Oliveira · Luca Di Tommaso · Norman Zerbe · Vincenzo L’Imperio · Sabine Declercq · Marc Van den Bulcke · Anouk Waeytens · Roberto Salgado · Amélie Dendooven, with the support of the European Society of Pathology and the European Society of Digital and Integrative Pathology – ESDIP.
At RheumaFinder, our expertise goes far beyond rheumatic disease detection. We actively support the implementation of AI and the AI Act in medicine in several ways.
By staying at the forefront of technological innovation, we’re laying the groundwork for automation and AI applications—key steps for compliance with the EU AI Act.
To read the Expert Opinion Paper, click here to access the Springer Nature platform.
